These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38175855)

  • 1. In-silico evaluation of natural alkaloids against the main protease and spike glycoprotein as potential therapeutic agents for SARS-CoV-2.
    Shah M; Yamin R; Ahmad I; Wu G; Jahangir Z; Shamim A; Nawaz H; Nishan U; Ullah R; Ali EA; Sheheryar ; Chen K
    PLoS One; 2024; 19(1):e0294769. PubMed ID: 38175855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19).
    El-Demerdash A; Metwaly AM; Hassan A; Abd El-Aziz TM; Elkaeed EB; Eissa IH; Arafa RK; Stockand JD
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach.
    Sabarimurugan S; Purushothaman I; Swaminathan R; Dharmarajan A; Warrier S; Kothandan S
    Acta Virol; 2021; 65(2):160-172. PubMed ID: 34130467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of terpenoids as potential inhibitors of SARS-CoV-2 (main protease) and spike (RBD) via computer-aided drug design.
    Hadni H; Fitri A; Touimi Benjelloun A; Benzakour M; Mcharfi M; Benbrahim M
    J Biomol Struct Dyn; 2024 Sep; 42(15):8145-8158. PubMed ID: 37548619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2: a computational approach for anti-COVID-19 drug discovery.
    Arunkumar M; Gunaseelan S; Kubendran Aravind M; Mohankumar V; Anupam P; Harikrishnan M; Siva A; Ashokkumar B; Varalakshmi P
    J Biomol Struct Dyn; 2022; 40(19):8961-8988. PubMed ID: 34014150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fourteen immunomodulatory alkaloids and two prenylated phenylpropanoids with dual therapeutic approach for COVID-19: molecular docking and dynamics studies.
    Omar R; Abd El-Salam M; Elsbaey M; Hassan M
    J Biomol Struct Dyn; 2024 Mar; 42(5):2298-2315. PubMed ID: 37116054
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus.
    Prashantha CN; Gouthami K; Lavanya L; Bhavanam S; Jakhar A; Shakthiraju RG; Suraj V; Sahana KV; Sujana HS; Guruprasad NM; Ramachandra R
    J Mol Graph Model; 2021 Jan; 102():107769. PubMed ID: 33152616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Computational Study of Carbazole Alkaloids from Murraya koenigii as Potential SARS-CoV-2 Main Protease Inhibitors.
    Wadanambi PM; Jayathilaka N; Seneviratne KN
    Appl Biochem Biotechnol; 2023 Jan; 195(1):573-596. PubMed ID: 36107386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies.
    Abdizadeh R; Hadizadeh F; Abdizadeh T
    J Biomol Struct Dyn; 2023; 41(13):5915-5945. PubMed ID: 35848354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of multiple SARS-CoV-2 proteins by an antiviral biomolecule, seselin from
    Nivetha R; Bhuvaragavan S; Muthu Kumar T; Ramanathan K; Janarthanan S
    J Biomol Struct Dyn; 2022; 40(21):11070-11081. PubMed ID: 34431451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emetine, a potent alkaloid for the treatment of SARS-CoV-2 targeting papain-like protease and non-structural proteins: pharmacokinetics, molecular docking and dynamic studies.
    Snoussi M; Redissi A; Mosbah A; De Feo V; Adnan M; Aouadi K; Alreshidi M; Patel M; Kadri A; Noumi E
    J Biomol Struct Dyn; 2022; 40(20):10122-10135. PubMed ID: 34254564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of phytoconstituents of
    Choudhary P; Singh T; Amod A; Singh S
    J Biomol Struct Dyn; 2023 Jun; 41(9):4106-4123. PubMed ID: 35467486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation.
    Gorla US; Rao K; Kulandaivelu US; Alavala RR; Panda SP
    Comb Chem High Throughput Screen; 2021; 24(6):879-890. PubMed ID: 32819226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational discovery of dual potential inhibitors of SARS-CoV-2 spike/ACE2 and M
    Bekono BD; Onguéné PA; Simoben CV; Owono LCO; Ntie-Kang F
    Eur Biophys J; 2024 Aug; 53(5-6):277-298. PubMed ID: 38907013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying plant-derived antiviral alkaloids as dual inhibitors of SARS-CoV-2 main protease and spike glycoprotein through computational screening.
    Yamin R; Ahmad I; Khalid H; Perveen A; Abbasi SW; Nishan U; Sheheryar S; Moura AA; Ahmed S; Ullah R; Ali EA; Shah M; Chandra Ojha S
    Front Pharmacol; 2024; 15():1369659. PubMed ID: 39086396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of bio-active Amaryllidaceae alkaloidal small molecules as putative SARS-CoV-2 main protease and host TMPRSS2 inhibitors: interpretation by
    Bhowmick S; Mistri TK; Khan MR; Patil PC; Busquets R; Ashif Ikbal AM; Choudhury A; Roy DK; Palit P; Saha A
    J Biomol Struct Dyn; 2024 Sep; 42(14):7107-7127. PubMed ID: 37482789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An efficient eco-friendly, simple, and green synthesis of some new spiro-N-(4-sulfamoyl-phenyl)-1,3,4-thiadiazole-2-carboxamide derivatives as potential inhibitors of SARS-CoV-2 proteases: drug-likeness, pharmacophore, molecular docking, and DFT exploration.
    El-Saghier AM; Enaili SS; Abdou A; Kadry AM
    Mol Divers; 2024 Feb; 28(1):249-270. PubMed ID: 37946070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Natural Bisbenzylisoquinoline Analogs from the Library of Thai Traditional Plants as SARS-CoV-2 3CL
    Khamto N; Utama K; Tateing S; Sangthong P; Rithchumpon P; Cheechana N; Saiai A; Semakul N; Punyodom W; Meepowpan P
    J Chem Inf Model; 2023 Apr; 63(7):2104-2121. PubMed ID: 36647612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
    Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
    J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.